BioAffinity Technologies Inc
NASDAQ:BIAF 4:00:00 PM EDT
| Market Cap (Intraday) | 9.92M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.25 |
| 50-Day MA | $1.67 |
| 200-Day MA | $1.82 |
BioAffinity Technologies Inc Stock, NASDAQ:BIAF
22211 West Interstate 10, Suite 1206, San Antonio, Texas 78257
United States of America
Phone: +1.210.698.5334
Number of Employees: 14
Description
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.